Du Plessis, Ilse2016-03-082016-03-082015-08Du Plessis, I 2015, 'Higher vigilance needed to diagnose and treat MDDs', Specialist Forum, vol. 15, no. 7, pp. 12.2218-8282http://hdl.handle.net/2263/51711Selective serotonin reuptake inhibitors (SSRIs) became the first line of treatment of depressive disorders (MDD) during the eighties and has kept its place in the arsenal of options to treat this common disease. MDD accounts for 4,4% of the total overall global disease burden.en.© The Specialist ForumTreatmentDiseaseMajor depressive disorder (MDD)Selective serotonin reuptake inhibitors (SSRIs)Article